The global infection control market is expected to exhibit strong growth during 2021-2026. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during the forecast period (2021-2026). Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.
Infection control refers to the process of eliminating or preventing the spread of contaminants in healthcare settings. It aims to ensure the safety of healthcare workers and patients by minimizing the exposure to pathogens, such as viruses, bacteria, parasites and fungi that can cause respiratory, ear, eye, skin and urinary tract infections. It involves several practices, such as standard immunizations, practicing care while sneezing and coughing and using protective clothing, such as gloves, masks and surgical drapes and gowns. Apart from this, cleaning, disinfecting and sterilizing objects and surfaces are other crucial infection control activities conducted in hospitals, clinics, laboratories and pharmaceutical and food manufacturing units.
The increasing prevalence of hospital-acquired infections (HAI) and chronic medical ailments is one of the key factors driving the growth of the market. Furthermore, as the coronavirus disease (COVID-19) pandemic continues to spread across the globe, there is an acute shortage of masks, personal protection equipment (PPE) and sanitization solutions. As a result, there has been a significant increase in the demand for infection control solutions in healthcare centers. In line with this, increasing health consciousness among the masses is also providing a boost to the market growth. Moreover, food manufacturers are increasingly emphasizing on sterilization and disinfection to minimize the risks of contamination and spoilage of food and beverages. Additionally, various product innovations, such as the development of single-use medical nonwoven devices and sanitizers with high-intensity infection prevention capabilities, are contributing to the growth of the market. Other factors, including the rising geriatric population that is more susceptible to infections, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global infection control market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type and end user.
Breakup by Type:
Breakup by End User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being 3M Company, Advanced Sterlization Products Services Inc. (Fortive Corporation), Belimed AG (Metall Zug), Cantel Medical Corp., Getinge AB, Matachana, Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.), MMM Münchener Medizin Mechanik GmbH, Pal International, Sterigenics U.S. LLC (Sotera Health Holdings LLC), Steris Corporation and TSO3 Inc. (Stryker Corporation).
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at